Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model - Takeaways - MDSpire

Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model

  • By

  • Qinghua Dong

  • Yiwei Luo

  • Xiaoyu Tang

  • Minye Li

  • Dianjie Chen

  • Zhengji He

  • Qun Xiao

  • Chen Zhi

  • Min Zhu

  • Hui Ma

  • January 24, 2026

  • 0 min

Share

  • 1

    Cancer patients are at high risk for severe influenza complications due to immunosuppression, with increased hospitalization and mortality rates.

  • 2

    Influenza vaccination significantly reduces infection risk and improves cancer treatment outcomes, yet uptake among cancer patients remains low.

  • 3

    Vaccine hesitancy among cancer patients in China is notably high at 42.06%, exceeding that of the general population, which is 35.5%.

  • 4

    The Health Belief Model (HBM) provides a framework for understanding factors influencing vaccine hesitancy among cancer patients.

  • 5

    This study aims to identify determinants of influenza vaccine hesitancy in cancer patients to inform targeted intervention strategies.

Original Source(s)

Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model

  • by Qinghua Dong, Yiwei Luo, Xiaoyu Tang, Minye Li, Dianjie Chen, Zhengji He, Qun Xiao, Chen Zhi, Min Zhu, Hui Ma

  • January 24, 2026

Related Content

Flu Vaccination Linked to Lower Heart, Stroke Risk After Infection

A Danish registry study suggests prior influenza vaccination is associated with lower short-term cardiovascular risk following breakthrough infection.

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle